Prevalence of gastrointestinal malignancy in non‐anemic iron deficiency and significance for endoscopic screening: A Western Australian multicenter cohort study
Journal of Gastroenterology and Hepatology · 2023
DOI: 10.1111/jgh.16215 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Gastroenterology and Hepatology, 2023. Verfasst von Samantha Hodges und 5 weiteren Autor:innen. Beteiligte Einrichtung: Fiona Stanley Fremantle Hospitals Group, Perth, Western Australia, Australia. Hauptthemen laut MEDLINE: Gastrointestinal Neoplasms, Anemia, Iron-Deficiency, Iron Deficiencies. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
Background and Aim There is a paucity of evidence regarding non‐anemic iron deficiency as a predictor for colorectal cancer and therefore the indication for endoscopic evaluation. This study explores the rates of malignancy in adults with iron deficiency with and without anemia.
Methods
A retrospective multicenter diagnostic cohort study was conducted across two Australian health services. All cases that underwent both esophagogastroduodenoscopy and colonoscopy between September 1, 2018, and December 31, 2019, for the investigation of iron deficiency were included, and the cohort was divided into anemic and non‐anemic arms. Multivariate binomial logistic regression was performed to establish clinical characteristics associated with neoplasia.
Results
Five hundred eighty‐four patients underwent endoscopic evaluation over a 16‐month period. There was a significantly higher rate of malignancy in the iron deficiency anemia arm as compared with those without anemia (8.76% vs 1.20%, P < 0.01). Gastrointestinal pathology to account for iron deficiency was identified in > 60% of the total cohort. The presence of anemia (odds ratio [OR] 6.87, P < 0.01) and male gender (OR 3.01, P = 0.01) were significant predictors of malignancy.
Conclusion
This study demonstrates that anemic iron deficiency confers a significantly greater risk of gastrointestinal cancer compared with non‐anemic iron deficiency. Additionally, over 60% of patients had gastrointestinal pathology to account for iron deficiency overall, supporting the need to perform baseline endoscopy in patients with iron deficiency.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Fiona Stanley Fremantle Hospitals Group, Perth, Western Australia, Australia.
- Royal Perth Bentley Group, Perth, Western Australia, Australia.
- Curtin University, Perth, Western Australia, Australia.
- Rockingham General Hospital, Perth, Western Australia, Australia.
ORCID-Profile: Samantha Hodges, Sherman Picardo
Zitieren
APA
Hodges, S., Attree, C., Picardo, S., Faithfull, T., McElholm, A., & Ragunath, K. (2023). Prevalence of gastrointestinal malignancy in non‐anemic iron deficiency and significance for endoscopic screening: A Western Australian multicenter cohort study. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16215
Vancouver
Hodges S, Attree C, Picardo S, Faithfull T, McElholm A, Ragunath K. Prevalence of gastrointestinal malignancy in non‐anemic iron deficiency and significance for endoscopic screening: A Western Australian multicenter cohort study. Journal of Gastroenterology and Hepatology. 2023. doi:10.1111/jgh.16215
BibTeX
@article{Hodges2023,
author = {Hodges, Samantha and Attree, Chloe and Picardo, Sherman and Faithfull, Tiffany and McElholm, Adrian and Ragunath, Krish},
title = {Prevalence of gastrointestinal malignancy in non‐anemic iron deficiency and significance for endoscopic screening: A Western Australian multicenter cohort study},
journal = {Journal of Gastroenterology and Hepatology},
year = {2023},
doi = {10.1111/jgh.16215}
}
EUVIMED